Investigation of the relationship between different Candida species and some risk factors affecting the incidence of Vulvovaginal Candidiasis [PDF]
Majallah-i Zanān, Māmā̓ī va Nāzā̓ī-i Īrān, 2019 Introduction: Vulvovaginal candidiasis (VVC) is a yeast infection and is one of the most common causes of women's referral to the physician. The aim of this study was to investigate the relationship between different Candida species and some risk factors
Seyedeh Sedigheh Hosseini +11 more
doaj +1 more source
Three-Dose Antifungal Treatment Improves the Efficacy for Severe Vulvovaginal Candidiasis. [PDF]
MycopathologiaXiao Z +5 more
europepmc +3 more sources
Modern concepts of etiopathogenesis and approaches to the treatment of recurrent vulvovaginal candidiasis [PDF]
Vestnik Dermatologii i Venerologii, 2023 Vulvovaginal candidiasis is a widespread infection caused by Candida. The disease affects 7580% of women of reproductive age at least once during their lifetime, and 920% of them indicate the presence of three or more episodes of the disease during the ...
Margarita R. Rakhmatulina
doaj +1 more source
β-Glucan induces reactive oxygen species production in human neutrophils to improve the killing of Candida albicans and Candida glabrata isolates from vulvovaginal candidiasis. [PDF]
PLoS ONE, 2014 Vulvovaginal candidiasis (VVC) is among the most prevalent vaginal diseases. Candida albicans is still the most prevalent species associated with this pathology, however, the prevalence of other Candida species, such as C. glabrata, is increasing.
Patricia de Souza Bonfim-Mendonça +9 more
doaj +1 more source
Clinical case: patient treated for vulvovaginal candidiasis
Клинический разбор в общей медицине, 2021 Case study of acute vulvovaginal candidiasis treated with medication containing dequalinium chloride as an active ingredient has been reported. Patient A.
Tatyana Yu. Pestrikova
doaj +1 more source
Vaginal lipidomics of women with vulvovaginal candidiasis and cytolytic vaginosis: A non-targeted LC-MS pilot study. [PDF]
PLoS ONE, 2018 OBJECTIVE:To characterize the lipid profile in vaginal discharge of women with vulvovaginal candidiasis, cytolytic vaginosis, or no vaginal infection or dysbiosis. DESIGN:Cross-sectional study.
José Marcos Sanches +8 more
doaj +1 more source
Efficacy and compliance of vulvovaginal candidiasis therapy during pregnancy [PDF]
РМЖ. Мать и дитя, 2018 Efficacy and compliance of vulvovaginal candidiasis therapy during pregnancy Tyutyunnik V.L., Khan N.E., Lomova N.A., Kokoeva D.N. National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.
Kan N.E., Lomova N.A., Kokoeva D.N.
doaj
Topical treatment for acute vulvovaginal candidiasis [PDF]
РМЖ. Мать и дитя, 2019 Topical treatment for acute vulvovaginal candidiasis V.G. Volkov Tula State University, Tula, Russian Federation Vulvovaginal candidiasis is a yeast infection of vulvar and vaginal mucosa caused by Candida species.
Volkov V.G.
doaj
Comparison of Single Dose Sertaconazole versus Three Dose Clotrimazole Regime in Treatment of Uncomplicated Vulvovaginal Candidiasis- A Prospective Study [PDF]
Journal of Clinical and Diagnostic Research, 2019 Introduction: Vulvovaginal candidiasis is the second most common vaginitis following bacterial vaginitis amongst the reproductive age group with variable compliance to the treatment.
Katha Desai, Pradip Sambarey
doaj +1 more source
Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis
Frontiers in Immunology, 2022 Recurrent vulvovaginal candidiasis (RVVC) and vulvovaginal candidiasis (RVVC) are one of the most common gynecological infections, primarily caused by Candida species. Although risk factors of RVVC and VVC have been identified in many studies, antifungal
Gai Ge +6 more
doaj +1 more source